ClinicalTrials.Veeva

Menu

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit (RADOS)

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Enrolling

Conditions

Bloodstream Infection
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT06624618
2023-0344

Details and patient eligibility

About

Rapid diagnosis of sepsis is crucial for treatment and survival. Currently, blood culture takes 48 hours-5 days to complete. After starting antimicrobial treatment blood culture results are not reliable. As a result, empirical broad spectrum antimicrobial therapy is mostly used. This implies possible antimicrobial over- or under treatment which is associated with increased antimicrobial resistance development. Early identification of the causative pathogen of sepsis will therefore have a major impact on the adequate treatment and reduction of high mortality rates. To date, there is not a single molecular diagnostic test available on the market to detect all putative causative bacterial pathogens of sepsis. In this study, the investigators will develop and validate a completely new molecular sepsis approach based on pathogen DNA detection, as an alternative to culture.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Patients are included when routine blood cultures are ordered for diagnosis of bloodstream infections.

Exclusion criteria

-N/A

Trial contacts and locations

1

Loading...

Central trial contact

Paul Savelkoul, Prof. Dr.; Anna Wijen, Msc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems